Cite

HARVARD Citation

    , . et al. (n.d.). PTH-131 Multi-centre comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn's disease. Gut. p. A100. [Online]. 
  
Back to record